| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.1991.00400090063012 |
| P698 | PubMed publication ID | 1679624 |
| P2093 | author name string | Deck C | |
| Radack K | |||
| P433 | issue | 9 | |
| P921 | main subject | meta-analysis | Q815382 |
| intermittent claudication | Q1097957 | ||
| randomized controlled trial | Q1436668 | ||
| claudication | Q2888709 | ||
| P304 | page(s) | 1769-1776 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials | |
| P478 | volume | 151 |
| Q36572355 | 2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations |
| Q92463060 | 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations |
| Q34566259 | ACE up the sleeve - are vascular patients medically optimized? |
| Q57796503 | Association of Blood Pressure Measurements With Peripheral Artery Disease Events |
| Q40591023 | Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction |
| Q33873267 | Beta-blockers for congestive heart failure: what is the current consensus? |
| Q36203168 | Beta-blockers in selected heart failure populations |
| Q37082599 | Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions |
| Q38574275 | Bisoprolol: Is This Just Another Beta-Blocker for Hypertension or Angina? |
| Q24245649 | Cardioselective beta-blockers for chronic obstructive pulmonary disease |
| Q34699281 | Cardioselective beta-blockers for chronic obstructive pulmonary disease. |
| Q51648717 | Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis. |
| Q40953069 | Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris |
| Q27015689 | Chapter III: Management of cardiovascular risk factors and medical therapy |
| Q40623187 | Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease |
| Q46642637 | Critical limb ischemia |
| Q26995245 | Critical limb ischemia: advanced medical therapy |
| Q33743880 | Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review |
| Q35951348 | Do beta-blockers have a role in treating hypertension? Yes. |
| Q26852616 | Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease? |
| Q28195312 | Drug treatment of peripheral arterial disease in the elderly |
| Q22241786 | ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary |
| Q73935847 | Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease |
| Q30979057 | Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease |
| Q33757625 | Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials |
| Q36829011 | How to treat hypertension in patients with peripheral artery disease |
| Q36141462 | Hydrogen Sulfide Levels and Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI). |
| Q38984352 | Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry |
| Q33630570 | Intermittent claudication in older patients. Practical treatment guidelines |
| Q93761295 | Les bêtabloquants ont-ils un rôle dans le traitement de l’hypertension?: OUI |
| Q27010121 | Limb salvage in women |
| Q22337455 | Management of Hypertension in Peripheral Arterial Disease: Does the Choice of Drugs Matter? |
| Q35020304 | Management of intermittent claudication |
| Q24655017 | Management of lower extremity peripheral arterial disease |
| Q36981330 | Medical management and cardiovascular risk reduction in peripheral arterial disease |
| Q35761784 | Optimal management of peripheral arterial disease for the non-specialist |
| Q37069056 | Peripheral arterial disease in the elderly |
| Q35990502 | Peripheral arterial disease of the lower extremities |
| Q37896022 | Peripheral arterial disease--what do we need to know? |
| Q37321632 | Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. |
| Q37889106 | Peripheral artery disease. Part 2: medical and endovascular treatment |
| Q33951581 | Peripheral artery disease: current insight into the disease and its diagnosis and management |
| Q34314049 | Peripheral vascular disease and hypertension: a forgotten association? |
| Q35091909 | Pharmacological treatment of patients with peripheral arterial disease |
| Q71870128 | Physician use of beta-adrenergic blocking therapy: a changing perspective |
| Q41670463 | Postinfarction use of beta-blockers in elderly patients |
| Q34707663 | Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension |
| Q34705824 | Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. |
| Q35073032 | Secondary Pharmacotherapeutic Prevention among German Primary Care Patients with Peripheral Arterial Disease |
| Q40650580 | Selection and use of beta-blockers for patients with cardiovascular disease |
| Q22306384 | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure |
| Q34995347 | Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment |
| Q34742246 | The heart, kidney, and brain as target organs in hypertension |
| Q36830299 | Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure |
| Q35023961 | Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve |
| Q37551266 | Treatment of hypertension in patients with peripheral arterial disease: an update |
| Q24201969 | Treatment of hypertension in peripheral arterial disease |
| Q34809362 | Use of cardiovascular medications in the elderly |
| Q79362920 | [Cardiovascular pharmacotherapy in the aged] |
| Q77652812 | [Quality of life and peripheral obliterative arteriopathy. Perspective for the future] |
Search more.